
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic barriers to cancer immunotherapy
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 377
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 377
Showing 1-25 of 377 citing articles:
Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 738
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 738
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 396
Jia Xiong, Jia He, Jun Zhu, et al.
Molecular Cell (2022) Vol. 82, Iss. 9, pp. 1660-1677.e10
Open Access | Times Cited: 396
Metabolic programming and immune suppression in the tumor microenvironment
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 249
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 249
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
Julia A. Belk, Winnie Yao, Nghi Ly, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 768-786.e7
Open Access | Times Cited: 212
Julia A. Belk, Winnie Yao, Nghi Ly, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 768-786.e7
Open Access | Times Cited: 212
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 172
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 172
Metabolic communication in the tumour–immune microenvironment
Kung‐Chi Kao, Stefania Vilbois, Chin‐Hsien Tsai, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 11, pp. 1574-1583
Closed Access | Times Cited: 172
Kung‐Chi Kao, Stefania Vilbois, Chin‐Hsien Tsai, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 11, pp. 1574-1583
Closed Access | Times Cited: 172
Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin, Yinan Shen, Tingbo Liang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Danni Lin, Yinan Shen, Tingbo Liang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Modulating Glycolysis to Improve Cancer Therapy
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 157
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 157
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
Paolo Vignali, Kristin DePeaux, McLane J. Watson, et al.
Nature Immunology (2022) Vol. 24, Iss. 2, pp. 267-279
Open Access | Times Cited: 154
Paolo Vignali, Kristin DePeaux, McLane J. Watson, et al.
Nature Immunology (2022) Vol. 24, Iss. 2, pp. 267-279
Open Access | Times Cited: 154
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy
Yingyue Ding, Yixin Wang, Quanyin Hu
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 149
Yingyue Ding, Yixin Wang, Quanyin Hu
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 149
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 147
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 147
Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 147
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 147
Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity
Carina B. Nava Lauson, Silvia Tiberti, Paola Antonia Corsetto, et al.
Cell Metabolism (2023) Vol. 35, Iss. 4, pp. 633-650.e9
Open Access | Times Cited: 140
Carina B. Nava Lauson, Silvia Tiberti, Paola Antonia Corsetto, et al.
Cell Metabolism (2023) Vol. 35, Iss. 4, pp. 633-650.e9
Open Access | Times Cited: 140
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 114
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 114
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
Federica Danzi, Raffaella Pacchiana, Andrea Mafficini, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 107
Federica Danzi, Raffaella Pacchiana, Andrea Mafficini, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 107
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
Yang Zhao, Jiangqing Chen, Massimo Andreatta, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 11, pp. 1693-1704
Closed Access | Times Cited: 83
Yang Zhao, Jiangqing Chen, Massimo Andreatta, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 11, pp. 1693-1704
Closed Access | Times Cited: 83
Tumor Abnormality-Oriented Nanomedicine Design
Quan Zhou, Jiajia Xiang, Nasha Qiu, et al.
Chemical Reviews (2023) Vol. 123, Iss. 18, pp. 10920-10989
Closed Access | Times Cited: 75
Quan Zhou, Jiajia Xiang, Nasha Qiu, et al.
Chemical Reviews (2023) Vol. 123, Iss. 18, pp. 10920-10989
Closed Access | Times Cited: 75
Amino Acid Metabolism in Cancer Drug Resistance
Hee-Chan Yoo, Jung Min Han
Cells (2022) Vol. 11, Iss. 1, pp. 140-140
Open Access | Times Cited: 73
Hee-Chan Yoo, Jung Min Han
Cells (2022) Vol. 11, Iss. 1, pp. 140-140
Open Access | Times Cited: 73
T Cell Exhaustion
Andrew Baessler, Dario A.A. Vignali
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 179-206
Closed Access | Times Cited: 62
Andrew Baessler, Dario A.A. Vignali
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 179-206
Closed Access | Times Cited: 62
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Md Arafat Khan, Parvez Κhan, Aatiya Ahmad, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 1-15
Open Access | Times Cited: 57
Md Arafat Khan, Parvez Κhan, Aatiya Ahmad, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 1-15
Open Access | Times Cited: 57
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 50
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 50